LABCORP HOLDINGS INC. Business Combination, Consideration Transferred
LABCORP HOLDINGS INC. (LH) reported Business Combination, Consideration Transferred of $528.60 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Consideration Transferred
us-gaap:BusinessCombinationConsiderationTransferred1 · last filed 2026-08-05
- LABCORP HOLDINGS INC. business combination, consideration transferred for the quarter ending 2026-06-30 was $216.60M.
- LABCORP HOLDINGS INC. business combination, consideration transferred for the quarter ending 2026-03-31 was $312.00M.
| Period end | Business Combination, Consideration Transferred 3 month | Business Combination, Consideration Transferred 6 month |
|---|---|---|
| 2026-06-30 | $216.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $528.60M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $312.00M 10-Q · filed 2026-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |